Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sumatriptan for Cilostazol-Induced Headache
NCT03422796Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Nov 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in migraine comparing Sumatriptan with Placebo (2 arms). Primary endpoints: Difference in median headache score after sumatriptan/placebo at 2 hours and Difference in AUC 0-4h post treatment. Started Nov 2017; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03422796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03422796.